Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Isotope & Radiation Corp. ( (HK:1763) ) has shared an update.
China Isotope & Radiation Corporation announced that its subsidiary Chengdu Gaotong Isotope Co., Ltd. has partnered with China National Nuclear Corporation Overseas Ltd. and Thailand-based Pondpol Analytical Co., Ltd. on a technical services contract for a secondary standardized neutron dosimetry laboratory. Under the arrangement, Chengdu Gaotong will supply products and related services, while China National Nuclear focuses on project management and supervision, with each party independently compensated and liable, keeping the deal outside Hong Kong connected-transaction thresholds.
The project will calibrate neutron radiation dose measuring instruments and support related scientific research, forming a key piece of nuclear technology infrastructure to strengthen Thailand’s national metrology system. Management describes the contract as a milestone in the company’s international expansion, positioning it to deepen its presence in Thailand, broaden its business across Southeast Asia and replicate similar nuclear technology projects in the region.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation is a PRC-based nuclear technology company focused on isotopes, radiation applications and related products and services. Through subsidiaries such as Chengdu Gaotong Isotope Co., Ltd., it serves both domestic and international markets, leveraging ties with China National Nuclear Corporation to expand its footprint in nuclear technology applications.
Average Trading Volume: 177,062
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.08B
Find detailed analytics on 1763 stock on TipRanks’ Stock Analysis page.